Literature DB >> 5311510

First clinical application of transarterial closed-chest left ventricular (TaCLV) bypass.

H H Zwart, A Kralios, C S Kwan-Gett, D K Backman, J L Foote, J D Andrade, F M Calton, F Schoonmaker, W J Kolff.   

Abstract

Mesh：

Year:  1970        PMID： 5311510

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN： 0066-0078


× No keyword cloud information.
  7 in total

1.  Transapical aortic cannulation for acute aortic dissection to prevent malperfusion and cerebral complications.

Authors:  S Yamamoto; Y Hosoda; M Yamasaki; N Ishikawa; K Fuchimoto; T Fukuda
Journal:  Tex Heart Inst J       Date:  2001

2.  Transapical aortic cannulation using a deep hypothermic procedure through a left thoracotomy for acute traumatic aortic rupture.

Authors:  Takahiro Takemura; Yoshiei Shimamura; Masayuki Sakaguchi; Yasutoshi Tsuda; Shizuko Iwasa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

3.  A NEW SIMPLIFIED SYSTEM FOR INTRAOPERATIVE COUNTERPULSATION.

Authors:  Yehuda Tamari; Martin J. Kaplitt
Journal:  Cardiovasc Dis       Date:  1978-03

4.  The role of assist devices in managing low cardiac output.

Authors:  John C. Norman
Journal:  Cardiovasc Dis       Date:  1981-03

5.  Twenty-four hour left ventricular bypass in the unanesthetized dog: a study employing transthoracic cannulation and a paracorporeal roller pump.

Authors:  W S Pierce; S Kazama; H Metz; G A Prophet; J A Waldhausen
Journal:  Ann Surg       Date:  1974-01       Impact factor: 12.969

6.  Impact of transapical aortic cannulation for acute type A aortic dissection.

Authors:  Etsuro Suenaga; Manabu Sato; Hideyuki Fumoto; Hiromitsu Kawasaki; Syugo Koga
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

7.  Aortic arch cannulation with the guidance of transesophageal echocardiography for Stanford type A aortic dissection.

Authors:  Hao Ma; Zhenghua Xiao; Jun Shi; Lulu Liu; Chaoyi Qin; Yingqiang Guo
Journal:  J Cardiothorac Surg       Date:  2018-10-11       Impact factor: 1.637
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.